Global Respiratory Care Devices Market Size study & Forecast, by Product (PAP Devices, Ventilators, Humidifiers, Oxygen Concentrators, Spirometers, Peak Flow Meter, Masks), by Disease Indication (Asthma, Infectious Disease), by End User (Hospitals, Homeca

The Global Respiratory Care Devices Market is valued at approximately USD 21.99 billion in 2024 and is anticipated to expand at a CAGR of 7.30% over the forecast period of 2025–2035. Respiratory care devices are critical medical equipment designed to support patients with acute and chronic respiratory disorders, enhancing oxygen delivery, monitoring lung function, and improving overall patient outcomes. These devices play a pivotal role in treating conditions such as asthma, chronic obstructive pulmonary disease (COPD), and respiratory infections while also providing life-saving support in intensive care units. The global market growth is underpinned by rising cases of respiratory illnesses, accelerated urban pollution levels, increasing adoption of home-based healthcare, and the expanding geriatric population susceptible to respiratory complications. Furthermore, advancements in portable respiratory technology and telehealth integration continue to shape the demand landscape positively.

The surge in infectious disease prevalence, particularly respiratory infections such as influenza, tuberculosis, and COVID-19, has dramatically amplified the demand for respiratory care devices across healthcare systems worldwide. The accelerated consumption of ventilators and oxygen concentrators during pandemic peaks has highlighted the critical role these devices play in life-support management. According to WHO, nearly 262 million people are affected by asthma globally, while COPD remains one of the leading causes of mortality worldwide. The rising burden of such diseases, coupled with lifestyle shifts, smoking prevalence, and occupational hazards, is propelling the adoption of respiratory care equipment. Meanwhile, technological progress in non-invasive ventilation, portable oxygen delivery systems, and AI-enabled respiratory monitoring has opened lucrative growth opportunities for manufacturers. However, cost barriers in low- and middle-income countries and a growing tilt toward preventive over therapeutic care pose challenges to sustained expansion.

The detailed segments and sub-segments included in the report are:

By Product:
• PAP Devices
• Ventilators
• Humidifiers
• Oxygen Concentrators
• Spirometers
• Peak Flow Meter
• Masks

By Disease Indication:
• Asthma
• Infectious Disease

By End User:
• Hospitals
• Homecare Settings

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Hospitals are Expected to Dominate the Market

Hospitals continue to represent the dominant end-user segment, accounting for the majority of respiratory care device usage. The growing demand for advanced ventilation systems in intensive care units, coupled with hospital-led adoption of modern respiratory diagnostics, underpins their market leadership. Hospitals benefit from established procurement channels and access to state-of-the-art respiratory support technologies, ensuring rapid adoption. Although hospitals hold the lion’s share, the homecare setting is emerging as a promising frontier, driven by a rising preference for home-based treatment solutions, cost-effectiveness, and greater convenience for patients managing chronic conditions. This dual dynamic reflects both the entrenched hospital dominance and the rising attractiveness of decentralized care.

Ventilators Lead in Revenue Contribution

Among product categories, ventilators contribute the highest revenue, supported by their indispensable role in critical and emergency care management. Their extensive deployment during global health crises further reinforced their indispensable value within intensive care settings. Simultaneously, oxygen concentrators and PAP devices are gaining prominence, largely due to their utility in homecare environments and chronic disease management. This indicates a market bifurcation: ventilators remain the backbone of revenue streams within acute care, whereas portable oxygen systems and PAP devices accelerate growth prospects in home settings. The current outlook paints ventilators as dominant revenue generators, while next-generation portable devices are steadily carving out rising market share.

The key regions considered for the Global Respiratory Care Devices Market study include North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America commanded the market in 2025, bolstered by its advanced healthcare infrastructure, high incidence of respiratory diseases, widespread insurance coverage, and rapid integration of innovative respiratory technologies. Meanwhile, Asia Pacific is poised to be the fastest-growing market, fueled by soaring pollution levels, increasing tobacco consumption, urbanization-driven disease prevalence, and government-backed investments in healthcare modernization. Countries such as China and India stand at the forefront of this surge, where an expanding patient pool and improved affordability are converging to accelerate adoption. Europe follows closely, benefiting from robust healthcare systems and a growing elderly population requiring respiratory support.

Major market players included in this report are:
• Philips Healthcare
• ResMed Inc.
• Medtronic plc
• Drägerwerk AG & Co. KGaA
• Hamilton Medical AG
• Fisher & Paykel Healthcare Corporation Limited
• Vyaire Medical, Inc.
• GE Healthcare
• Smiths Medical (ICU Medical Inc.)
• Masimo Corporation
• Nihon Kohden Corporation
• Becton, Dickinson and Company
• 3M Healthcare
• Honeywell International Inc.
• Mindray Medical International Limited

Global Respiratory Care Devices Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional-level analysis for each market segment.
• Detailed analysis of the geographical landscape with country-level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of the competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more